Increase/Decrease in Cash: The total change in cash for the company over the given period.
Metagenomi, Inc. (MGX) had Increase/Decrease in Cash of $5.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$8.66M |
|
$-20.39M |
|
-- |
|
$8.66M |
|
$31.50M |
|
$-22.84M |
|
$2.21M |
|
$-20.63M |
|
$-20.63M |
|
$-20.39M |
|
$-20.39M |
|
$-20.39M |
|
$-20.39M |
|
$-22.84M |
|
$-22.34M |
|
37.35M |
|
37.35M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$189.82M |
|
$13.89M |
|
$58.12M |
|
$247.94M |
|
$29.58M |
|
-- |
|
$39.91M |
|
$69.49M |
|
$178.45M |
|
$178.45M |
|
$178.45M |
|
37.55M |
|
| Cash Flow Statement Financials | |
$-65.35M |
|
$71.16M |
|
$-0.43M |
|
$32.63M |
|
$38.02M |
|
|
Increase/Decrease in Cash |
$5.39M |
$9.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-263.76% |
|
-263.76% |
|
-- |
|
-238.21% |
|
-235.51% |
|
$-65.80M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
9.02 |
|
9.98 |
|
-11.43% |
|
-11.43% |
|
-8.23% |
|
-11.43% |
|
$4.75 |
|
$-1.76 |
|
$-1.75 |
|